|
| Exchange Disseminated Time 23/01/2017 11:53:47 | Suven Life Sciences Ltd has informed BSE that a Board Meeting of the Company will be held on February 01, 2017, inter alia, to consider and take on record the following matter(s):
1. To consider and approve the Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended December 31, 2016
2. To consider declaration of Interim Dividend, if any, for the financial year 2016-17 and related matters etc. and
Further, the TRADING WINDOW for dealing in the securities of the Company is closed from January 23, 2017 to February 03, 2017 (both days inclusive). Trading window will be opened from February 04, 2017. |
|
|